In a previous study we demonstrated that lncRNA-p21 level is increased after Enzalutamide treatment and promotes NED of PCa through regulating Enhancer of Zeste Homolog 2/signal transducer and activator of transcription 3 signaling (20). Here, EZH2 is linked to posterior cortical atrophy.